WILDCAT CAPITAL MANAGEMENT, LLC Allogene Therapeutics, Inc. Transaction History

WILDCAT CAPITAL MANAGEMENT, LLC portfolio value:

$22.98M
portfolio value

WILDCAT CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-5.26%
quarter

Allogene Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -1.27M $10.8 2.12M
Q2 2022 share 0.00% 0 shares 4.87M $11.4 2.12M
Q1 2022 share Increase +24.00% 412K shares -6.21M $9.11 2.12M
Q4 2021 share 0.00% 0 shares -18.50M $15.38 1.71M
Q3 2021 share 0.00% 0 shares -652K $25.7 1.71M
Q2 2021 share Increase +13.25% 200.84K shares -8.73M $26.08 1.71M
Q1 2021 share 0.00% 0 shares 15.24M $35.3 1.51M
Q4 2020 share 0.00% 0 shares -18.89M $25.24 1.51M
Q3 2020 share 0.00% 0 shares -7.74M $37.71 1.51M
Q2 2020 share Increase +12.29% 165.88K shares 38.65M $42.82 1.51M
Q1 2020 share Increase +12.30% 147.81K shares -4.98M $19.44 1.34M
Q4 2019 share Increase +32.62% 295.63K shares 6.52M $25.98 1.20M
Q3 2019 share Increase +70.28% 374.02K shares 10.40M $27.26 906.19K
Q2 2019 share Increase 0.00% 532.16K shares 14.28M $26.85 532.16K